Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.2746
-0.0074 (-2.62%)
Sep 2, 2025, 12:53 PM - Market open

Intensity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
1327117---
Upgrade
Market Cap Growth
-88.54%-77.37%----
Upgrade
Enterprise Value
1224102---
Upgrade
Last Close Price
0.281.768.57---
Upgrade
PB Ratio
3.389.118.93---
Upgrade
P/TBV Ratio
6.249.118.93---
Upgrade
Debt / Equity Ratio
0.060.050.01-0.881.780.06
Upgrade
Quick Ratio
1.021.483.730.191.236.96
Upgrade
Current Ratio
1.401.923.910.211.277.04
Upgrade
Return on Equity (ROE)
-334.12%-202.34%-261.36%--161.84%-75.07%
Upgrade
Return on Assets (ROA)
-122.67%-93.90%-54.58%-135.34%-65.19%-40.77%
Upgrade
Return on Capital (ROIC)
-206.15%-126.59%-81.79%-309.17%-79.52%-46.24%
Upgrade
Earnings Yield
-92.28%-61.19%-8.97%---
Upgrade
Buyback Yield / Dilution
-13.30%-61.40%-152.67%--0.02%-0.19%
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q